The share touched its 52-week high Rs 550.40 and 52-week low Rs 337.85 on 22 January, 2019 and 24 July, 2019, respectively.
Shares of Strides Pharma Science added more than 3 percent intraday on September 20 after company board approved additional investment in Stelis Biopharma.
The company has approved an additional investment up to a maximum of USD 40 million over a period of 24 months for a controlling stake in Stelis Biopharma, as per BSE release.
The proposed new investments will be a primary infusion into Stelis which will enable Stelis to achieve its objective of becoming a compelling global player in the biopharmaceutical space and also accelerate Strides’ re-entry into sterile injectables business post the completion of the company’s non-compete period in December 2019.
At 13:22 hrs Strides Pharma Science was quoting at Rs 370.80, up Rs 11.45, or 3.19 percent on the BSE.
The share touched its 52-week high Rs 550.40 and 52-week low Rs 337.85 on 22 January, 2019 and 24 July, 2019, respectively.Currently, it is trading 32.63 percent below its 52-week high and 9.75 percent above its 52-week low.Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.